Autophagy in Mycobacterium tuberculosis infection: A passepartout to flush the intruder out?

Cytokine and Growth Factor Reviews

Volumn 24, Issue 4, 2013, Pages 335-343

  Goletti, Delia ^a   Petruccioli, Elisa ^a   Romagnoli, Alessandra ^a   Piacentini, Mauro ^a,b   Fimia, Gian Maria ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Anti tuberculosis drugs; Autophagy; Autophagy gene polymorphisms; Inflammatory cytokines; Mycobacterium tuberculosis

Indexed keywords

CALCITRIOL; COLECALCIFEROL; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; ISONIAZID; NITAZOXANIDE; RAPAMYCIN;

AUTOPHAGY; BACTERIAL INFECTION; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEGRADATION KINETICS; DRUG EFFECT; DRUG RESPONSE; GENETIC POLYMORPHISM; HIGH RISK BEHAVIOR; HUMAN; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RISK REDUCTION; SHORT SURVEY; SIGNAL TRANSDUCTION; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

ANTI-TUBERCULOSIS DRUGS; AUTOPHAGY; AUTOPHAGY GENE POLYMORPHISMS; INFLAMMATORY CYTOKINES; MYCOBACTERIUM TUBERCULOSIS;

ANIMALS; ANTITUBERCULAR AGENTS; AUTOPHAGY; CYTOKINES; HUMANS; IMMUNE EVASION; INFLAMMATION; MICE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 84883797212     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2013.01.002     Document Type: Short Survey

References (99)

1. WHO. REPORT 2012, http://www.who.int/tb/publications/global_report/en/.
2. Gengenbacher M., Kaufmann S.H. Mycobacterium tuberculosis: success through dormancy. FEMS Microbiology Review 2012, 36:514-532.
3. Armstrong J.A., Hart P.D. Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. Journal of Experimental Medicine 1975, 142:1-16.
4. Kaufmann S.H. How can immunology contribute to the control of tuberculosis?. Nature Reviews Immunology 2001, 1:20-30.
5. Russell D.G. Mycobacterium tuberculosis: here today, and here tomorrow. Nature Reviews Molecular Cell Biology 2001, 2:569-577.
6. Russell D.G., Mwandumba H.C., Rhoades E.E. Mycobacterium and the coat of many lipids. Journal of Cell Biology 2002, 158:421-426.
7. van Crevel R., Ottenhoff T.H., van der Meer J.W. Innate immunity to Mycobacterium tuberculosis. Advances in Experimental Medicine and Biology 2003, 531:241-247.
8. Reece S.T., Kaufmann S.H. Floating between the poles of pathology and protection: can we pin down the granuloma in tuberculosis?. Current Opinion in Microbiology 2012, 15:63-70.
9. Flynn J.L., Goldstein M.M., Chan J., Triebold K.J., Pfeffer K., Lowenstein C.J., et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995, 2:561-572.
10. Manca C., Tsenova L., Bergtold A., Freeman S., Tovey M., Musser J.M., et al. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:5752-5757.
11. Casanova J.L., Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annual Review of Immunology 2002, 20:581-620.
12. Gallegos A.M., van Heijst J.W., Samstein M., Su X., Pamer E.G., Glickman M.S. A gamma interferon independent mechanism of CD4 T cell mediated control of M. tuberculosis infection in vivo. PLoS Pathogens 2011, 7:e1002052.
13. Bumbacea D., Arend S.M., Eyuboglu F., Fishman J.A., Goletti D., Ison M.G., et al. The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement. European Respiratory Journal 2012, 40:990-1013.
14. Solovic I., Sester M., Gomez-Reino J.J., Rieder H.L., Ehlers S., Milburn H.J., et al. The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement. European Respiratory Journal 2010, 36:1185-1206.
15. Harris J. Autophagy and cytokines. Cytokine 2011, 56:140-144.
16. Rook G.A. Th2 cytokines in susceptibility to tuberculosis. Current Molecular Medicine 2007, 7:327-337.
17. Tomioka H., Tatano Y., Sano C., Shimizu T. Development of new antituberculous drugs based on bacterial virulence factors interfering with host cytokine networks. Journal of Infection and Chemotherapy 2011, 17:302-317.
18. Ottenhoff T.H. New pathways of protective and pathological host defense to mycobacteria. Trends in Microbiology 2012, 20:419-428.
19. Mizushima N., Levine B., Cuervo A.M., Klionsky D.J. Autophagy fights disease through cellular self-digestion. Nature 2008, 451:1069-1075.
20. Kroemer G., Marino G., Levine B. Autophagy and the integrated stress response. Molecular Cell 2010, 40:280-293.
21. Mizushima N. The role of the Atg1/ULK1 complex in autophagy regulation. Current Opinion in Cell Biology 2010, 22:132-139.
22. Fimia G.M., Corazzari M., Antonioli M., Piacentini M. Ambra1 at the crossroad between autophagy and cell death. Oncogene 2012.
23. Matsunaga K., Morita E., Saitoh T., Akira S., Ktistakis N.T., Izumi T., et al. Autophagy requires endoplasmic reticulum targeting of the PI3-kinase complex via Atg14L. Journal of Cell Biology 2010, 190:511-521.
24. Zalckvar E., Berissi H., Mizrachy L., Idelchuk Y., Koren I., Eisenstein M., et al. DAP-kinase-mediated phosphorylation on the BH3 domain of beclin 1 promotes dissociation of beclin 1 from Bcl-XL and induction of autophagy. EMBO Reports 2009, 10:285-292.
25. Wei Y., Pattingre S., Sinha S., Bassik M., Levine B. JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Molecular Cell 2008, 30:678-688.
26. Shi C.S., Kehrl J.H. TRAF6 and A20 regulate lysine 63-linked ubiquitination of Beclin-1 to control TLR4-induced autophagy. Science Signaling 2010, 3:ra42.
27. Platta H.W., Abrahamsen H., Thoresen S.B., Stenmark H. Nedd4-dependent lysine-11-linked polyubiquitination of the tumour suppressor Beclin 1. Biochemical Journal 2012, 441:399-406.
28. Johansen T., Lamark T. Selective autophagy mediated by autophagic adapter proteins. Autophagy 2011, 7:279-296.
29. Shaid S., Brandts C.H., Serve H., Dikic I. Ubiquitination and selective autophagy. Cell Death and Differentiation 2012.
30. Wild P., Farhan H., McEwan D.G., Wagner S., Rogov V.V., Brady N.R., et al. Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science 2011, 333:228-233.
31. Pilli M., Arko-Mensah J., Ponpuak M., Roberts E., Master S., Mandell M.A., et al. TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation. Immunity 2012, 37:223-234.
32. Thurston T.L., Wandel M.P., von Muhlinen N., Foeglein A., Randow F. Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion. Nature 2012, 482:414-418.
33. Orvedahl A., Levine B. Eating the enemy within: autophagy in infectious diseases. Cell Death and Differentiation 2009, 16:57-69.
34. Deretic V. Autophagy as an innate immunity paradigm: expanding the scope and repertoire of pattern recognition receptors. Current Opinion in Immunology 2012, 24:21-31.
35. Munz C. Enhancing immunity through autophagy. Annual Review of Immunology 2009, 27:423-449.
36. Lee H.K., Lund J.M., Ramanathan B., Mizushima N., Iwasaki A. Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 2007, 315:1398-1401.
37. Travassos L.H., Carneiro L.A., Ramjeet M., Hussey S., Kim Y.G., Magalhaes J.G., et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nature Immunology 2010, 11:55-62.
38. Jounai N., Kobiyama K., Shiina M., Ogata K., Ishii K.J., Takeshita F. NLRP4 negatively regulates autophagic processes through an association with beclin1. Journal of Immunology 2011, 186:1646-1655.
39. Saitoh T., Akira S. Regulation of innate immune responses by autophagy-related proteins. Journal of Cell Biology 2010, 189:925-935.
40. Randow F., Munz C. Autophagy in the regulation of pathogen replication and adaptive immunity. Trends in Immunology 2012, 33:475-487.
41. Lee H.K., Mattei L.M., Steinberg B.E., Alberts P., Lee Y.H., Chervonsky A., et al. In vivo requirement for Atg5 in antigen presentation by dendritic cells. Immunity 2010, 32:227-239.
42. Nedjic J., Aichinger M., Emmerich J., Mizushima N., Klein L. Autophagy in thymic epithelium shapes the T-cell repertoire and is essential for tolerance. Nature 2008, 455:396-400.
43. Pua H.H., Dzhagalov I., Chuck M., Mizushima N., He Y.W. A critical role for the autophagy gene Atg5 in T cell survival and proliferation. Journal of Experimental Medicine 2007, 204:25-31.
44. Mortensen M., Soilleux E.J., Djordjevic G., Tripp R., Lutteropp M., Sadighi-Akha E., et al. The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance. Journal of Experimental Medicine 2011, 208:455-467.
45. Gutierrez M.G., Master S.S., Singh S.B., Taylor G.A., Colombo M.I., Deretic V. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 2004, 119:753-766.
46. Kumar D., Nath L., Kamal M.A., Varshney A., Jain A., Singh S., et al. Genome-wide analysis of the host intracellular network that regulates survival of Mycobacterium tuberculosis. Cell 2010, 140:731-743.
47. Castillo E.F., Dekonenko A., Arko-Mensah J., Mandell M.A., Dupont N., Jiang S., et al. Autophagy protects against active tuberculosis by suppressing bacterial burden and inflammation. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:E3168-E3176.
48. Singh S.B., Davis A.S., Taylor G.A., Deretic V. Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 2006, 313:1438-1441.
49. Singh S.B., Ornatowski W., Vergne I., Naylor J., Delgado M., Roberts E., et al. Human IRGM regulates autophagy and cell-autonomous immunity functions through mitochondria. Nature Cell Biology 2010, 12:1154-1165.
50. Kim B.H., Shenoy A.R., Kumar P., Das R., Tiwari S., MacMicking J.D. A family of IFN-gamma-inducible 65-kD GTPases protects against bacterial infection. Science 2011, 332:717-721.
51. Ponpuak M., Davis A.S., Roberts E.A., Delgado M.A., Dinkins C., Zhao Z., et al. Delivery of cytosolic components by autophagic adaptor protein p62 endows autophagosomes with unique antimicrobial properties. Immunity 2010, 32:329-341.
52. Petruccioli E., Romagnoli A., Corazzari M., Coccia E.M., Butera O., Delogu G., et al. Specific T cells restore the autophagic flux inhibited by Mycobacterium tuberculosis in human primary macrophages. Journal of Infectious Diseases 2012, 205:1425-1435.
53. Romagnoli A., Etna M.P., Giacomini E., Pardini M., Remoli M.E., Corazzari M., et al. ESX-1 dependent impairment of autophagic flux by Mycobacterium tuberculosis in human dendritic cells. Autophagy 2012, 8:1357-1370.
54. Shin D.M., Jeon B.Y., Lee H.M., Jin H.S., Yuk J.M., Song C.H., et al. Mycobacterium tuberculosis eis regulates autophagy, inflammation, and cell death through redox-dependent signaling. PLoS Pathogens 2010, 6:e1001230.
55. Zhang L., Zhang H., Zhao Y., Mao F., Wu J., Bai B., et al. Effects of Mycobacterium tuberculosis ESAT-6/CFP-10 fusion protein on the autophagy function of mouse macrophages. DNA and Cell Biology 2012, 31:171-179.
56. Kim K.H., An D.R., Song J., Yoon J.Y., Kim H.S., Yoon H.J., et al. Mycobacterium tuberculosis Eis protein initiates suppression of host immune responses by acetylation of DUSP16/MKP-7. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:7729-7734.
57. Kathania M., Raje C.I., Raje M., Dutta R.K., Majumdar S. Bfl-1/A1 acts as a negative regulator of autophagy in mycobacteria infected macrophages. International Journal of Biochemistry and Cell Biology 2011, 43:573-585.
58. Karim A.F., Chandra P., Chopra A., Siddiqui Z., Bhaskar A., Singh A., et al. Express path analysis identifies a tyrosine kinase Src-centric network regulating divergent host responses to Mycobacterium tuberculosis infection. Journal of Biological Chemistry 2011, 286:40307-40319.
59. Watson R.O., Manzanillo P.S., Cox J.S. Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway. Cell 2012, 150:803-815.
60. Manzanillo P.S., Shiloh M.U., Portnoy D.A., Cox J.S. Mycobacterium tuberculosis activates the DNA-dependent cytosolic surveillance pathway within macrophages. Cell Host & Microbe 2012, 11:469-480.
61. Salgame P. Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection. Current Opinion in Immunology 2005, 17:374-380.
62. Harris J., Hope J.C., Keane J. Tumor necrosis factor blockers influence macrophage responses to Mycobacterium tuberculosis. Journal of Infectious Diseases 2008, 198:1842-1850.
63. Kim J.J., Lee H.M., Shin D.M., Kim W., Yuk J.M., Jin H.S., et al. Host cell autophagy activated by antibiotics is required for their effective antimycobacterial drug action. Cell Host & Microbe 2012, 11:457-468.
64. Kleinnijenhuis J., Oosting M., Plantinga T.S., van der Meer J.W., Joosten L.A., Crevel R.V., et al. Autophagy modulates the Mycobacterium tuberculosis-induced cytokine response. Immunology 2011, 134:341-348.
65. Ladel C.H., Blum C., Dreher A., Reifenberg K., Kopf M., Kaufmann S.H. Lethal tuberculosis in interleukin-6-deficient mutant mice. Infection and Immunity 1997, 65:4843-4849.
66. Leal I.S., Smedegard B., Andersen P., Appelberg R. Interleukin-6 and interleukin-12 participate in induction of a type 1 protective T-cell response during vaccination with a tuberculosis subunit vaccine. Infection and Immunity 1999, 67:5747-5754.
67. Nagabhushanam V., Solache A., Ting L.M., Escaron C.J., Zhang J.Y., Ernst J.D. Innate inhibition of adaptive immunity: Mycobacterium tuberculosis-induced IL-6 inhibits macrophage responses to IFN-gamma. Journal of Immunology 2003, 171:4750-4757.
68. Dutta R.K., Kathania M., Raje M., Majumdar S. IL-6 inhibits IFN-gamma induced autophagy in Mycobacterium tuberculosis H37Rv infected macrophages. International Journal of Biochemistry and Cell Biology 2012, 44:942-954.
69. Harris J., De Haro S.A., Master S.S., Keane J., Roberts E.A., Delgado M., et al. T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. Immunity 2007, 27:505-517.
70. Andrade R.M., Wessendarp M., Gubbels M.J., Striepen B., Subauste C.S. CD40 induces macrophage anti-Toxoplasma gondii activity by triggering autophagy-dependent fusion of pathogen-containing vacuoles and lysosomes. Journal of Clinical Investigation 2006, 116:2366-2377.
71. Subauste C.S., Andrade R.M., Wessendarp M. CD40-TRAF6 and autophagy-dependent anti-microbial activity in macrophages. Autophagy 2007, 3:245-248.
72. Larkin R., Benjamin C.D., Hsu Y.M., Li Q., Zukowski L., Silver R.F. CD40 ligand (CD154) does not contribute to lymphocyte-mediated inhibition of virulent Mycobacterium tuberculosis within human monocytes. Infection and Immunity 2002, 70:4716-4720.
73. Campos-Neto A., Ovendale P., Bement T., Koppi T.A., Fanslow W.C., Rossi M.A., et al. CD40 ligand is not essential for the development of cell-mediated immunity and resistance to Mycobacterium tuberculosis. Journal of Immunology 1998, 160:2037-2041.
74. Shi C.S., Shenderov K., Huang N.N., Kabat J., Abu-Asab M., Fitzgerald K.A., et al. Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinated inflammasomes for destruction. Nature Immunology 2012, 13:255-263.
75. Zhou R., Yazdi A.S., Menu P., Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011, 469:221-225.
76. Nakahira K., Haspel J.A., Rathinam V.A., Lee S.J., Dolinay T., Lam H.C., et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nature Immunology 2011, 12:222-230.
77. Harris J., Hartman M., Roche C., Zeng S.G., O'Shea A., Sharp F.A., et al. Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation. Journal of Biological Chemistry 2011, 286:9587-9597.
78. Dupont N., Jiang S., Pilli M., Ornatowski W., Bhattacharya D., Deretic V. Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1beta. EMBO Journal 2011, 30:4701-4711.
79. Hmama Z., Nandan D., Sly L., Knutson K.L., Herrera-Velit P., Reiner N.E. 1alpha, 25-dihydroxyvitamin D(3)-induced myeloid cell differentiation is regulated by a vitamin D receptor-phosphatidylinositol 3-kinase signaling complex. Journal of Experimental Medicine 1999, 190:1583-1594.
80. Martineau A.R., Timms P.M., Bothamley G.H., Hanifa Y., Islam K., Claxton A.P., et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 2011, 377:242-250.
81. Yuk J.M., Shin D.M., Lee H.M., Yang C.S., Jin H.S., Kim K.K., et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host & Microbe 2009, 6:231-243.
82. Shin D.M., Yuk J.M., Lee H.M., Lee S.H., Son J.W., Harding C.V., et al. Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor signalling. Cellular Microbiology 2010, 12:1648-1665.
83. Fabri M., Stenger S., Shin D.M., Yuk J.M., Liu P.T., Realegeno S., et al. Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages. Science Translational Medicine 2011, 3. 104ra102.
84. Campbell G.R., Spector S.A. Vitamin D inhibits human immunodeficiency virus type 1 and Mycobacterium tuberculosis infection in macrophages through the induction of autophagy. PLoS Pathogens 2012, 8:e1002689.
85. Lam K.K., Zheng X., Forestieri R., Balgi A.D., Nodwell M., Vollett S., et al. Nitazoxanide stimulates autophagy and inhibits mTORC1 signaling and intracellular proliferation of Mycobacterium tuberculosis. PLoS Pathogens 2012, 8:e1002691.
86. Zullo A.J., Lee S. Old antibiotics target TB with a new trick. Cell Host & Microbe 2012, 11:419-420.
87. Jagannath C., Lindsey D.R., Dhandayuthapani S., Xu Y., Hunter R.L., Eissa N.T. Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells. Nature Medicine 2009, 15:267-276.
88. Fleming A., Noda T., Yoshimori T., Rubinsztein D.C. Chemical modulators of autophagy as biological probes and potential therapeutics. Nature Chemical Biology 2011, 7:9-17.
89. Intemann C.D., Thye T., Niemann S., Browne E.N., Amanua Chinbuah M., Enimil A., et al. Autophagy gene variant IRGM -261T contributes to protection from tuberculosis caused by Mycobacterium tuberculosis but not by M. africanum strains. PLoS Pathogens 2009, 5:e1000577.
90. King K.Y., Lew J.D., Ha N.P., Lin J.S., Ma X., Graviss E.A., et al. Polymorphic allele of human IRGM1 is associated with susceptibility to tuberculosis in African Americans. PLoS One 2011, 6:e16317.
91. Che N., Li S., Gao T., Zhang Z., Han Y., Zhang X., et al. Identification of a novel IRGM promoter single nucleotide polymorphism associated with tuberculosis. Clinica Chimica Acta 2010, 411:1645-1649.
92. Bahari G., Hashemi M., Taheri M., Naderi M., Eskandari-Nasab E., Atabaki M. Association of IRGM polymorphisms and susceptibility to pulmonary tuberculosis in Zahedan, Southeast Iran. Scientific World Journal 2012, 2012:950801.
93. Di Virgilio F. The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. Immunology Today 1995, 16:524-528.
94. Lammas D.A., Stober C., Harvey C.J., Kendrick N., Panchalingam S., Kumararatne D.S. ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors. Immunity 1997, 7:433-444.
95. Stober C.B., Lammas D.A., Li C.M., Kumararatne D.S., Lightman S.L., McArdle C.A. ATP-mediated killing of Mycobacterium bovis bacille Calmette-Guerin within human macrophages is calcium dependent and associated with the acidification of mycobacteria-containing phagosomes. Journal of Immunology 2001, 166:6276-6286.
96. Biswas D., Qureshi O.S., Lee W.Y., Croudace J.E., Mura M., Lammas D.A. ATP-induced autophagy is associated with rapid killing of intracellular mycobacteria within human monocytes/macrophages. BMC Immunology 2008, 9:35.
97. Fernando S.L., Saunders B.M., Sluyter R., Skarratt K.K., Wiley J.S., Britton W.J. Gene dosage determines the negative effects of polymorphic alleles of the P2X7 receptor on adenosine triphosphate-mediated killing of mycobacteria by human macrophages. Journal of Infectious Diseases 2005, 192:149-155.
98. Li C.M., Campbell S.J., Kumararatne D.S., Bellamy R., Ruwende C., McAdam K.P., et al. Association of a polymorphism in the P2X7 gene with tuberculosis in a Gambian population. Journal of Infectious Diseases 2002, 186:1458-1462.
99. Songane M., Kleinnijenhuis J., Alisjahbana B., Sahiratmadja E., Parwati I., Oosting M., et al. Polymorphisms in autophagy genes and susceptibility to tuberculosis. PLoS One 2012, 7:e41618.